ESCM
AEON icon

Echo Street Capital Management’s AEON Biopharma AEON Stock Holding History

Echo Street Capital Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,389
Closed -$975K – 609
2021
Q3 		$975K Buy
+1,389
New +$970K 0.01% 250

Other funds holding AEON

ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Echo Street Capital Management's AEON Position: Q4 2021 in Review

Echo Street Capital Management sold out of AEON Biopharma (AEON) in Q4 2021, closing a stake of 1,389 shares — an estimated $975K sold.

Echo Street Capital Management first reported a position in AEON in Q3 2021 and held it in 1 quarter. The position peaked at $975K in Q3 2021. 73 funds tracked by Wall St. Rank hold AEON as of Q4 2021.

  • Echo Street Capital Management reported no remaining AEON Biopharma position as of Q4 2021 after selling out during the quarter.
  • Echo Street Capital Management sold 1,389 AEON Biopharma shares in Q4 2021, an estimated $975K.
  • Echo Street Capital Management first reported a position in AEON Biopharma in Q3 2021 and held it in 1 quarter.
  • Echo Street Capital Management's AEON Biopharma position peaked at $975K in Q3 2021.
  • 73 funds tracked by Wall St. Rank held AEON Biopharma as of Q4 2021.

Based on Echo Street Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.